1. Home
  2. Clinical Topics
  3. FDA approves first generic capecitabine to treat breast and colorectal cancers
Clinical TopicsDrugs and DevicesGastroenterologyNewsOncologyWeb ExclusivesWomen's Health

FDA approves first generic capecitabine to treat breast and colorectal cancers

Share

On Sept. 16, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), used to treat metastatic breast and colorectal cancer. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts